Markéta Kazderová

Charles University in Prague, Praha, Hlavni mesto Praha, Czech Republic

Are you Markéta Kazderová?

Claim your profile

Publications (6)15.57 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: Clinical experience with mycophenolate mofetil (MMF) in glomerulonephritis still remains limited. In order to assess the experience of one center with the efficacy and tolerability of MMF in patients with glomerulonephritis, we performed a retrospective 6-year analysis of 68 patients treated by MMF for glomerular disease, mainly anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV: n=34) and systemic lupus erythematosus and lupus nephritis (SLE: n=24). Indications were maintenance treatment in 40% of patients, induction treatment in patients not tolerating cyclophosphamide in 27%, and disease relapse in 33%. Mean treatment duration was 11.5 months. Efficacy endpoints were serum creatinine, urinary protein excretion, and steroid dose. In AAV patients, MMF was associated with significant improvement in 18%, partial improvement in 26%, stabilization in 29%, and disease progression in 12%; adverse event dropouts totalled 15%. In SLE, the respective figures were 30, 22, 9, and 22%, with 17% adverse event dropouts. The most frequent side effects were gastrointestinal events (n=7) and infections (n=3). None was life-threatening and there were no deaths. MMF, in the relatively low doses used, was safe and effective, stabilizing or improving AAV in 73% of patients and SLE in 61%. Further prospective randomized controlled trials with MMF in renal vasculitis and lupus nephritis are clearly warranted.
    Archives of Medical Research 02/2008; 39(1):115-9. · 2.08 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The receptor for advanced glycation end products (RAGE) is involved in the pathogenesis of vascular and inflammatory diseases. The pathological effects mediated via RAGE are physiologically inhibited by soluble RAGE (sRAGE). Our aim was to study sRAGE and RAGE gene polymorphisms in haemodialysis (HD) patients. A total of 261 stable HD patients were enrolled in the study and prospectively followed up for 30 months. At the begining of the study, sRAGE inflammatory and nutritional parameters were determined. RAGE polymorphisms were determined in a subgroup of 214 HD patients. A group of 100 healthy controls was used for comparison. In HD patients, sRAGE is elevated in comparison with healthy controls (3427+/-1508 vs 1758+/-637 pg/ml, P<0.001). It correlates negatively with residual diuresis (r=-0.193, P<0.05), with the acute phase reactants fibrinogen (r=-0.174, P<0.05) and orosomucoid (r=-0.135, P<0.05) and with the leucocyte count (r=-0.158, P<0.05). On the other hand, it is not related to the presence of diabetes mellitus, cardiovascular disease, nutritional status and mortality. The highest sRAGE levels are found in -429 CC and 2184 GG polymorphisms of the RAGE gene. The same results as for sRAGE were obtained for endogenous secretory RAGE (esRAGE), which correlated significantly with sRAGE (r=0.88, P<0.001). We conclude that in HD patients, sRAGE is increased due to decreased renal function, which is a very strong determinant of sRAGE levels, and is inversely related to inflammation. The highest sRAGE levels are influenced genetically. In our study, sRAGE levels were not related to mortality of HD patients.
    Nephrology Dialysis Transplantation 07/2007; 22(7):2020-6. · 3.37 Impact Factor
  • Source
    J Krtil, J Pláteník, M Kazderová, V Tesar, T Zima
    [Show abstract] [Hide abstract]
    ABSTRACT: Podocytes (glomerular visceral epithelial cells) cover the exterior surface of the glomerular capillaries and contribute to the glomerular filtration membrane. Failure of podocyte function is involved in the progression of chronic glomerular disease; accordingly, research interest into podocyte biology is driven by the need for better protection and perhaps recovery of these cells in renal diseases. This review aims at summarizing available techniques for podocyte cell cultures from both the past and present, with special attention to the currently used methods. The establishment of classical primary cultures is based on isolation of glomeruli by differential sieving. Plating of glomeruli onto a collagen surface is followed by an outgrowth of cobblestone-like cells that, after replating, differentiate into arborized, mature podocytes. Currently, the majority of research studies use immortalized podocytic cell lines most often derived from transgenic mice bearing a conditional immortalizing gene. The podocytes can also be collected and cultured from healthy or diseased animal or patient urine. The urinary podocytes obtained from subjects with active glomerulopathies display higher proliferation potential and viability in vitro, perhaps due to disease-induced transdifferentiation. Finally, a list of phenotypic markers useful for identification and characterization of the cultured podocytic elements is provided.
    Kidney and Blood Pressure Research 02/2007; 30(3):162-74. · 1.60 Impact Factor
  • Source
    L Vojtová, T Zima, V Tesar, M Kazderová
    [Show abstract] [Hide abstract]
    ABSTRACT: Heavy proteinuria may be caused by either increased glomerulal basement membrane permeability or membrane or podocyte structural damage, and also by impairment of secretion-reabsorption tubular processes. The precise composition of modified or degraded urine proteins in proteinuria is not known. However, a possible toxic effect of proteins on tubular cells and disease progression is assumed. In this study, 15 patients with nephrotic proteinuria and other diagnoses (systemic lupus erythematodes with renal involvement (lupus nephritis) and AAV) were analysed by the 2D electrophoresis method. We have studied sample stability during storage, the albumin separation effect on sample analyses using ammonium sulphate, and the effect of proteases on the protein spectrum. In the first step, the proteins were divided by the isoelectric focusing method using polyacrylamide strips (pH 3-10 linear). The second step involved two-dimensional SDS electrophoresis performed in 12% polyacrylamide gel, which separated proteins according to their molecular weight. The proteins were visualized by the silver method. The gels were evaluated by Phoretix 2D expression software 2005. We found out that samples are stable for more than 6 months provided that they are frozen to -80 degrees C. The separation of albumin caused higher lucidity of the urinary proteomes. Without adding protease inhibitors we could detect proteolysis with increased quantity of proteins manifested in the area of about 10 kDa and decreased quantity of proteins detectable in the area with molecular weights about 50 kDa.
    Folia biologica 02/2007; 53(2):58-65. · 1.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Advanced glycation end products (AGEs) accumulate in patients with decreased renal function and exert various toxic effects through the receptor for AGEs (RAGE). Soluble RAGE (sRAGE) is a naturally occurring inhibitor of AGE-RAGE action. The aim of the study is to describe the relationship of sRAGE to renal function and dialysis modalities. The studied group consisted of 81 patients: 25 patients with various degrees of decreased renal function, 20 long-term hemodialysis (HD) patients, 15 peritoneal dialysis (PD) patients, and 21 healthy age-matched subjects. sRAGE was assessed immunochemically (enzyme-linked immunosorbent assay), and routine biochemical parameters were measured by means of certified methods. sRAGE level correlates positively with serum creatinine concentration (r = 0.50; P < 0.05), and its relationship to creatinine clearance is hyperbolic. sRAGE levels are elevated significantly, mainly in patients with end-stage renal disease (3,119.0 +/- 968.4 pg/mL in HD patients and 3,652.7 +/- 1,677.7 pg/mL in PD patients versus 1,405.1 +/- 426.1 pg/mL in controls; both P < 0.001 versus controls). In PD patients, sRAGE is detectable in spent dialysate (median, 75.8 pg/mL), correlates with its serum levels (r = 0.67; P < 0.05), and is related to protein losses in dialysate. In HD patients, sRAGE levels increase by 50% (P < 0.001) from 0 to 15 minutes during both HD and hemodiafiltration, and then decrease until the end of the session. Serum sRAGE levels increase in patients with decreased renal function, mainly patients with end-stage renal disease. It remains to be elucidated whether the increase is caused just by decreased renal function or whether sRAGE is upregulated to protect against toxic effects of AGEs.
    American Journal of Kidney Diseases 03/2006; 47(3):406-11. · 5.29 Impact Factor
  • Vladimír Tesar, Markéta Kazderová, Ludmila Hlavácková
    [Show abstract] [Hide abstract]
    ABSTRACT: Karl Rokitansky, Professor of Pathology at the University of Vienna described polyarteritis nodosa in 1852 in a 23 year old man with a 5-day history of fever and diarrhoea.
    Journal of nephrology 01/2004; 17(1):172-4. · 2.02 Impact Factor